CAR T and Adoptive T Cell Therapy(Omeros)

N/A

Report date: 2025/12/25 14:59:51

Base Information

Drug NameCAR T and Adoptive T Cell Therapy(Omeros)

Drug Alias NameAdoptive T Cell and CAR T Therapy(Omeros)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOmeros Corp

China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A